alexion acquir portola billion deal alexion
attempt expand beyond continu
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim feb
price data may
rate updat may
currenc amount express
methodolog valu compani
may alexion announc agreement acquir
portola deal valu billion buy-out
price per share lofti yet hardli unpreced
premium recent trade level repres
discount portola earli januari share
price look deal think price right
question logic ad portola andexxa
uncontrol bleed alexion portfolio rare-
ultra-rare-diseas drug point expect
materi chang fair valu estim per share
narrow-moat alexion
portola recent suffer tepid sale growth
andexxa
effect certain
anticoagul well failur bevyxxa
anticoagul gain regulatori approv europ
focu improv commerci andexxa
bevyxxa paus pipelin develop
cerdulatinib syk/jak inhibitor certain lymphoma
patient suppos move registr
trial year
first blush see mani synergi unlock
purchas portola andexxa specialti drug
sold hospit typic urgent care set
impli differ commerci strategi
alexion therapi chronic rare diseas alexion
manag team disclos substanti overlap
alexion hospit network portola target
account assuag concern
nonetheless remain skeptic move expect
alexion invest heavili move andexxa forward
addit diversifi alexion revenu
stream expect substanti strengthen
alexion competit posit alreadi
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note adjust net incom includ adjust differ non-gaap share
special develop market drug
rare life-threaten medic condit blockbust product soliri
approv paroxysm nocturn hemoglobinuria
neuromyel optica spectrum disord nmosd next-gener
ultomiri approv pnh ahu strensiq kanuma target
ultrarar metabol diseas alexion pipelin target rare diseas
high unmet need hematolog nephrolog metabol diseas neurolog
cardiolog area
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
precari posit given competit threat rare-
diseas drug soliri ultomiri
despit question opportun cost deal
alexion plenti dri powder busi develop
size deal seem reason find
andexxa efficaci compel drug avail
revers effect factor xa inhibitor caus
uncontrol life-threaten bleed small portion
roughli patient believ
alexion wing andexxa achiev peak sale
million slightli visibl alpha consensu estim
invest salesforc trial confirmatori
data label expans
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
